Inventor
AMANTINI DAVID
IT15 patents
⚠️ This page may combine multiple inventors who share the name “AMANTINI DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GALAPAGOS NV
10 patentsUS9926281B2Mar 27, 2018
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV6 citations81
US10487060B2Nov 26, 2019
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV4 citations70
US11564923B2Jan 31, 2023
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV2 citations68
US11718588B2Aug 8, 2023
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV0 citations59
US10941117B2Mar 9, 2021
5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV0 citations59
US12472181B2Nov 18, 2025
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV0 citations56
US11136325B2Oct 5, 2021
Pyrrolopyrimidine and pyrrolopyridine derivatives
GALAPAGOS NV0 citations56
US12264156B2Apr 1, 2025
Compounds and pharmaceutical compositions thereof for the treatment of diseases
GALAPAGOS NV0 citations46
US10829478B2Nov 10, 2020
5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritis
GALAPAGOS NV0 citations37
US10550100B2Feb 4, 2020
5-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritis
GALAPAGOS NV0 citations37
ALVARO GIUSEPPE
4 patentsUS8129384B2Mar 6, 2012
Imidazo[1,2-a]pyrazines as orexin receptor antagonists
ALVARO GIUSEPPE7 citations83
US8093255B2Jan 10, 2012
Imidazo[1,2-A]pyrimidines as orexin receptor antagonists
ALVARO GIUSEPPE8 citations83
US8153623B2Apr 10, 2012
Compounds
ALVARO GIUSEPPE9 citations81
US8133908B2Mar 13, 2012
Heteroaryl derivatives of N-{[(1S,4S,6S)-3-(2-pyridinylcarbonyl)-3-azabicyclo[4.1.0]hept-4-yl]methyl}-2-amine
ALVARO GIUSEPPE10 citations79